Quarterly report · Q2
3937.TEDINET S100PJRL
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥4.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥502m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥436m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥478m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥466m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥832m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥350m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥350m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥5.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥5.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥498m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥874m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥498m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥33m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥203m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥48m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥235m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥152m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥97m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥28.58 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.24 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.63 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.79 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.88 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.49 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.81 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.7% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥159m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥216m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥444m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥45m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥45m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥162m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥199m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥740m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥399m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥598m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥598m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)AKIRA KONISHI（常任代理人 株式会社Ubicomホールディングス） | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)MUNTINLUPACITY METRO MANILA PHILIPPINES（東京都文京区小石川２丁目23番11号） | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)UBS AG LONDON ASIA EQUITIES（常任代理人 シティバンク、エヌ・エイ東京支店） | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)5 BROADGATE LONDON EC2M 2QS UK（東京都新宿区新宿６丁目27番30号） | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)THE BANK OF NEW YORK MELLON140042（常任代理人 株式会社みずほ銀行決済営業部 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)松下 順一 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)760 MOORE ROAD KING OF PRUSSIA, PA 19406（東京都新宿区新宿６丁目27番30号） | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社Ubicomホールディングス | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都文京区小石川二丁目23番11号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |